Quidel | QDEL - Current Assets


Quidel reported $1.37B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Agilent USD 4.59B 341M Sep/2025
Avanos Medical USD 351.4M 4.6M Sep/2025
Becton, Dickinson and Co. USD 9.26B 258M Sep/2025
Bruker USD 2.35B 187.9M Sep/2025
Charles River Laboratories USD 1.53B 62.24M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Exact Sciences USD 1.59B 82.87M Sep/2025
Haemonetics USD 899.68M 13.48M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 2.8B 155M Sep/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Mettler Toledo International USD 1.28B 36.74M Sep/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Neogen USD 574.58M 50.52M Sep/2025
Quidel USD 1.37B 85.2M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
STAAR Surgical USD 321.21M 28.42M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Waters USD 1.92B 137.07M Sep/2025